Summary
II were markedly increased in a dosedependent manner in the indomethacin-treated and in the untreated groups. At 60 min after the injection of renin ANG I concentrations decreased in both groups. However, the fall in ANG I in cerebrospinal fluid was more marked in indomethacinpretreated animals.
4. Renin in doses of 0401, 0.01 and 0.1 unit was injected into the lateral brain ventricles of unanaesthetized normotensive rats. A dosedependent, long-lasting (>2 h) increase in blood pressure of 9, 15 and 20% was observed. In conscious rats pretreated with indomethacin the blood pressure effects of the renin were greater (12, 23,27%) when compared with results for untreated controls.
5. Intracerebroventricular injection into con- doses of 1 and 10 pglkg reduced or abolished the renin-induced increases in blood pressure.
6. The results demonstrate that ANG I as well as ANG I1 are generated from brain angiotensinogen. The endogenously formed ANG I1 increases arterial blood pressure. This effect can be inhibited by brain intraventricular administration of specific ANG I1 antagonists, but it can be increased by inhibition of prostaglandin biosynthesis.
Introduction
The central actions of angiotensin (ANG) to increase arterial blood pressure, stimulate thirst, release pituitary hormones and interfere with memory processes are elicited by injection of ANG I1 directly into the brain (Severs & Daniels-Severs, 1973; Morgan & Routtenberg, 1977) . There is an increasing body of evidence for the existence of an endogenous renin-angiotensin system in brain (Ganten & Speck, 1978 Gimbrone & Alexander, 1975 ). An interaction of the brain renin-angiotensin system with P G seems probable since part of the central actions of ANG, the drinking response, can be suppressed by intracerebroventricular injection of arachidonic acid and PGE, (Fluharty & Epstein, 1979) . The present experiments in rats were carried out to evaluate the influence of PG on the local generation of ANG from brain angiotensinogen in cerebrospinal fluid and on blood pressure effects of brain ANG.
Methods

Blood pressure effects of intracerebraventricular renin
Experiments were carried out in male SpragueDawley rats, weighing 270-420 g. Implantation of a cannula into the lateral cerebral ventricle and blood pressure measurements were done as described by Mann, Phillips, Dietz, Haebara & The rats were awake, unrestrained and freely moving during testing and recording (n = 141).
. Enzyme assay in vivo
Three to 4 days after implantation of the cannula in the lateral ventricle, rats were anaesthetized with pentobarbital and mounted in a stereotaxic instrument. The membrane atlanto-occipitalis was dissected and a 18 Record needle connected to PE-20 tubing was inserted into the fourth brain ventricle with a micromanipulator. Renin was injected into the ventricle in doses of 0.001, 0.01 or 0.1 unit.
Cerebrospinal fluid was drained and collected into plastic vials containing angiotensinase inhibitor placed on ice 15 and 60 min after the injection of renin (n = 104). Angiotensinogen, ANG I and ANG I1 were determined by radioimmunoassay. In protocol 1 and 2 rats were pretreated with indomethacin (5 mg/kg subcutaneously) every other day for 10 days.
Nephrectomy
Bilateral nephrectomy was performed in rats (n = 37) and 16-20 h after nephrectomy renin was given intracerebroventricularly and blood was collected. ANG I, ANG I1 and renh activity in plasma were determined by radioimmunoassay.
Values are given as means f s e of the means.
Results were analysed by Student's paired and unpaired t-test if appropriate, and linear regression analysis. The 5% probability was used as the criterion of significance. 
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artificial cerebrospinal fluid were without influence on arterial blood pressure in conscious rats. At 15 min after the renin injections concentrations of ANG I and ANG I1 in cerebrospinal fluid were markedly increased (P < 0.05) in a dosedependent manner in the indomethacin-pretreated and in the untreated groups, and angiotensinogen decreased. The fall in ANG I concentration at 60 min was more marked in indomethacin-pretreated animals: ANG I concentration in cerebrospinal fluid was 1903 f. 347 fmol/ml after 0.01 unit of renin in controls, a d 452 +_ 119 fmol/ml in indomethacin-pretreated rats (P < 0.001). In bilaterally nephrectomized rats the renin injections were without influence on ANG I, ANG I1 and renin activity in plasma.
Discussion
Angiotensinogen is present in high concentrations in cerebrospinal fluid (Printz & Lewicki, 1977; Ganten & Speck, 1978) . It decreased after intracerebroventricular injections of renin, indicating that ANG I was cleaved from its high-molecularweight precursor angiotensinogen in cerebrospinal fluid as was also found for dogs (G. Sponer, U. Ganten, P. Schelling & D. Ganten, unpublished work) . In nephrectomized rats no change in plasma ANG I, ANG I1 and renin activity before and after intracerebroventricular injection of renin was observed, indicating that formation of ANG was a local phenomenon. The inhibitory effects of the pretreatment with ANG I1 antagonists also support this conclusion. The cerebrospinal fluid ANG I and subsequent conversion into ANG I1 was dosedependent. At 15 min after the renin injections ANG I and ANG I1 concentrations in cerebrospinal fluid were similarly increased in the indomethacin-treated and in the untreated groups. At 60 min after the injection of renin ANG I concentrations decreased in both groups, but the fall in ANG I was more marked in indomethacinpretreated rats. In view of the effects of PG on enzymatic renin activity (Kotchen & Miller, 1974; Zahn & Ganten, 1976 ) and on renin release (Frolich, Hollifield, Dormois, Frolich, Seyberth, Michelakis & Oates, 1976; Romero, Dunlap & Strong, 1976) , it can be concluded that the decreased brain PG concentrations after indomethacin treatment (Wolfe et al., 1976; Abdel-H h ef al., 1978) are involved in the decrease of ANG I in cerebrospinal fluid at 60 rnin. The stimulation of brain ANG I1 was followed by a dosedependent increase in blood pressure after intracerebroventricular renin injections (Reid & Moffat, 1978) . Pretreatment with PG biosynthesis inhibitor indomethacin in doses sufficient to inhibit PG biosynthesis in rat brain (Abdel-Halim et al., 1978) significantly increased the blood pressure effects of endogenous brain ANG. In acute experiments in rats meclofenamate injected intracerebroventricularly had no significant effect on the blood pressure response of ANG I1 injected into the lateral ventricle (Phillips & Hoffman, 1977) . However, the augmented central pressor response to ANG I1 after indomethacin treatment could also be considered as a consequence of the removal of PG inhibition on sympathetic vasoconstrictor activity (Fredholm & Hedqvist, 1975) , thus increasing the sensitivity of the peripheral vascular beds to vasoconstrictor substances which are released into the blood after central ANG I1 stimulation.
